In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report
Abstract The aim of this in-vitro experimental study was to design a novel drug delivery system that may permit controlled release of N-acetylcysteine (NAC) following intratympanic administration. The system was composed of two different solutions that attained a hydrogel form within seconds after g...
Gespeichert in:
Veröffentlicht in: | American journal of otolaryngology 2015-11, Vol.36 (6), p.786-793 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 793 |
---|---|
container_issue | 6 |
container_start_page | 786 |
container_title | American journal of otolaryngology |
container_volume | 36 |
creator | Ciftci, Zafer, MD Deniz, Mahmut, MD Yilmaz, Ibrahim, MSc Ciftci, Halide Gunes, MD Sirin, Duygu Yasar, PhD Gultekin, Erdogan, MD |
description | Abstract The aim of this in-vitro experimental study was to design a novel drug delivery system that may permit controlled release of N-acetylcysteine (NAC) following intratympanic administration. The system was composed of two different solutions that attained a hydrogel form within seconds after getting into contact with each other. The authors performed swelling, pH and temperature tests and analysis of controlled release of NAC from this novel controlled release system. For the structure and porosity analysis of the hydrogel, an environmental scanning electron microscope (SEM) was used. The diameter of designed hydrogel showed an increase when pH was increased. In addition, in comparison to acidic values, the pore diameter of the hydrogel increased significantly especially in physiological level. The increase in the pore diameter was also directly proportional to the increase in temperature. Spectrophotometric analysis showed that the amount of NAC released into the medium was statistically significant ( p = 0.038, t = − 2.18, 95% CI; DF: 27). SEM analysis of the samples revealed a smooth surface topography and numerous porous structures. The authors are of the opinion that the designed hydrogel may be used as an alternative method for intratympanic delivery of NAC for otoprotective purposes. The disadvantages of intratympanic injection of the drug in its liquid form, including leakage through eustachian tube, restraining the patient in an uncomfortable position, necessity for repetitive injections and dose dependent inflammation of the middle ear epithelium, may also be avoided. Further in vivo studies should be conducted to assess its tolerability and effectivity. |
doi_str_mv | 10.1016/j.amjoto.2015.08.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1746892225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019607091500174X</els_id><sourcerecordid>3860565461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-e04433271d604e8ca79bdebf785039b5d85aff0712d021f80d07ab5148503f0a3</originalsourceid><addsrcrecordid>eNqNks-KFDEQxhtR3HH1DUQCXrx0W0kn3WkPgiz-WVj0oMLeQiaplozpZEx6BvoVfGrTzKiwFz0Fqn71Ffm-qqqnFBoKtHu5a_S0i3NsGFDRgGwA-L1qQ0XLaknl7f1qA3ToauhhuKge5bwDgJa34mF1wTrBBe_Zpvp5HcjRzSkSHbRfssskjkSTEI_oiYmhtLxHSxJ61BlJXvKME7GY3bdQ6mNMxBVKz8u018EZou3kgstrycWwyn2stcF58WaddQFflQX7IugKqNNStPcxzY-rB6P2GZ-c38vq67u3X64-1Def3l9fvbmpDe_lXCNw3rasp7YDjtLoftha3I69FNAOW2Gl0OMIPWUWGB0lWOj1VlC-9kfQ7WX14qS7T_HHAfOsJpcNeq8DxkNWtOedHBhj4j_Qlvay7Xhf0Od30F08pOLpmRo4pVAofqJMijknHNU-ual4oCioNVa1U6dY1RqrAqlKrGXs2Vn8sJ3Q_hn6nWMBXp8ALMYdHSaVjcNg0LqEZlY2un9tuCtgfEnRaP8dF8x__6IyU6A-r6e1XhYVAMWw2_YXY6LMGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1731794110</pqid></control><display><type>article</type><title>In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ciftci, Zafer, MD ; Deniz, Mahmut, MD ; Yilmaz, Ibrahim, MSc ; Ciftci, Halide Gunes, MD ; Sirin, Duygu Yasar, PhD ; Gultekin, Erdogan, MD</creator><creatorcontrib>Ciftci, Zafer, MD ; Deniz, Mahmut, MD ; Yilmaz, Ibrahim, MSc ; Ciftci, Halide Gunes, MD ; Sirin, Duygu Yasar, PhD ; Gultekin, Erdogan, MD</creatorcontrib><description>Abstract The aim of this in-vitro experimental study was to design a novel drug delivery system that may permit controlled release of N-acetylcysteine (NAC) following intratympanic administration. The system was composed of two different solutions that attained a hydrogel form within seconds after getting into contact with each other. The authors performed swelling, pH and temperature tests and analysis of controlled release of NAC from this novel controlled release system. For the structure and porosity analysis of the hydrogel, an environmental scanning electron microscope (SEM) was used. The diameter of designed hydrogel showed an increase when pH was increased. In addition, in comparison to acidic values, the pore diameter of the hydrogel increased significantly especially in physiological level. The increase in the pore diameter was also directly proportional to the increase in temperature. Spectrophotometric analysis showed that the amount of NAC released into the medium was statistically significant ( p = 0.038, t = − 2.18, 95% CI; DF: 27). SEM analysis of the samples revealed a smooth surface topography and numerous porous structures. The authors are of the opinion that the designed hydrogel may be used as an alternative method for intratympanic delivery of NAC for otoprotective purposes. The disadvantages of intratympanic injection of the drug in its liquid form, including leakage through eustachian tube, restraining the patient in an uncomfortable position, necessity for repetitive injections and dose dependent inflammation of the middle ear epithelium, may also be avoided. Further in vivo studies should be conducted to assess its tolerability and effectivity.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2015.08.004</identifier><identifier>PMID: 26545472</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetylcysteine - administration & dosage ; Biocompatible Materials ; Borates ; Chitosan ; Delayed-Action Preparations ; Design ; Drug Delivery Systems ; Drug dosages ; Free Radical Scavengers - administration & dosage ; Humans ; Hydrogel, Polyethylene Glycol Dimethacrylate ; Hydrogels ; Hydrogen-Ion Concentration ; In Vitro Techniques ; Inflammation ; Injections ; Microscopy, Electron, Scanning ; Molecular weight ; Otolaryngology ; Patients ; Pharmaceutical sciences ; Polyvinyl Alcohol ; Spectrophotometry ; Studies ; Sulfur ; Surgery ; Temperature ; Tympanic Membrane</subject><ispartof>American journal of otolaryngology, 2015-11, Vol.36 (6), p.786-793</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-e04433271d604e8ca79bdebf785039b5d85aff0712d021f80d07ab5148503f0a3</citedby><cites>FETCH-LOGICAL-c478t-e04433271d604e8ca79bdebf785039b5d85aff0712d021f80d07ab5148503f0a3</cites><orcidid>0000-0003-3307-085X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S019607091500174X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26545472$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ciftci, Zafer, MD</creatorcontrib><creatorcontrib>Deniz, Mahmut, MD</creatorcontrib><creatorcontrib>Yilmaz, Ibrahim, MSc</creatorcontrib><creatorcontrib>Ciftci, Halide Gunes, MD</creatorcontrib><creatorcontrib>Sirin, Duygu Yasar, PhD</creatorcontrib><creatorcontrib>Gultekin, Erdogan, MD</creatorcontrib><title>In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>Abstract The aim of this in-vitro experimental study was to design a novel drug delivery system that may permit controlled release of N-acetylcysteine (NAC) following intratympanic administration. The system was composed of two different solutions that attained a hydrogel form within seconds after getting into contact with each other. The authors performed swelling, pH and temperature tests and analysis of controlled release of NAC from this novel controlled release system. For the structure and porosity analysis of the hydrogel, an environmental scanning electron microscope (SEM) was used. The diameter of designed hydrogel showed an increase when pH was increased. In addition, in comparison to acidic values, the pore diameter of the hydrogel increased significantly especially in physiological level. The increase in the pore diameter was also directly proportional to the increase in temperature. Spectrophotometric analysis showed that the amount of NAC released into the medium was statistically significant ( p = 0.038, t = − 2.18, 95% CI; DF: 27). SEM analysis of the samples revealed a smooth surface topography and numerous porous structures. The authors are of the opinion that the designed hydrogel may be used as an alternative method for intratympanic delivery of NAC for otoprotective purposes. The disadvantages of intratympanic injection of the drug in its liquid form, including leakage through eustachian tube, restraining the patient in an uncomfortable position, necessity for repetitive injections and dose dependent inflammation of the middle ear epithelium, may also be avoided. Further in vivo studies should be conducted to assess its tolerability and effectivity.</description><subject>Acetylcysteine - administration & dosage</subject><subject>Biocompatible Materials</subject><subject>Borates</subject><subject>Chitosan</subject><subject>Delayed-Action Preparations</subject><subject>Design</subject><subject>Drug Delivery Systems</subject><subject>Drug dosages</subject><subject>Free Radical Scavengers - administration & dosage</subject><subject>Humans</subject><subject>Hydrogel, Polyethylene Glycol Dimethacrylate</subject><subject>Hydrogels</subject><subject>Hydrogen-Ion Concentration</subject><subject>In Vitro Techniques</subject><subject>Inflammation</subject><subject>Injections</subject><subject>Microscopy, Electron, Scanning</subject><subject>Molecular weight</subject><subject>Otolaryngology</subject><subject>Patients</subject><subject>Pharmaceutical sciences</subject><subject>Polyvinyl Alcohol</subject><subject>Spectrophotometry</subject><subject>Studies</subject><subject>Sulfur</subject><subject>Surgery</subject><subject>Temperature</subject><subject>Tympanic Membrane</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks-KFDEQxhtR3HH1DUQCXrx0W0kn3WkPgiz-WVj0oMLeQiaplozpZEx6BvoVfGrTzKiwFz0Fqn71Ffm-qqqnFBoKtHu5a_S0i3NsGFDRgGwA-L1qQ0XLaknl7f1qA3ToauhhuKge5bwDgJa34mF1wTrBBe_Zpvp5HcjRzSkSHbRfssskjkSTEI_oiYmhtLxHSxJ61BlJXvKME7GY3bdQ6mNMxBVKz8u018EZou3kgstrycWwyn2stcF58WaddQFflQX7IugKqNNStPcxzY-rB6P2GZ-c38vq67u3X64-1Def3l9fvbmpDe_lXCNw3rasp7YDjtLoftha3I69FNAOW2Gl0OMIPWUWGB0lWOj1VlC-9kfQ7WX14qS7T_HHAfOsJpcNeq8DxkNWtOedHBhj4j_Qlvay7Xhf0Od30F08pOLpmRo4pVAofqJMijknHNU-ual4oCioNVa1U6dY1RqrAqlKrGXs2Vn8sJ3Q_hn6nWMBXp8ALMYdHSaVjcNg0LqEZlY2un9tuCtgfEnRaP8dF8x__6IyU6A-r6e1XhYVAMWw2_YXY6LMGQ</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Ciftci, Zafer, MD</creator><creator>Deniz, Mahmut, MD</creator><creator>Yilmaz, Ibrahim, MSc</creator><creator>Ciftci, Halide Gunes, MD</creator><creator>Sirin, Duygu Yasar, PhD</creator><creator>Gultekin, Erdogan, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3307-085X</orcidid></search><sort><creationdate>20151101</creationdate><title>In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report</title><author>Ciftci, Zafer, MD ; Deniz, Mahmut, MD ; Yilmaz, Ibrahim, MSc ; Ciftci, Halide Gunes, MD ; Sirin, Duygu Yasar, PhD ; Gultekin, Erdogan, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-e04433271d604e8ca79bdebf785039b5d85aff0712d021f80d07ab5148503f0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acetylcysteine - administration & dosage</topic><topic>Biocompatible Materials</topic><topic>Borates</topic><topic>Chitosan</topic><topic>Delayed-Action Preparations</topic><topic>Design</topic><topic>Drug Delivery Systems</topic><topic>Drug dosages</topic><topic>Free Radical Scavengers - administration & dosage</topic><topic>Humans</topic><topic>Hydrogel, Polyethylene Glycol Dimethacrylate</topic><topic>Hydrogels</topic><topic>Hydrogen-Ion Concentration</topic><topic>In Vitro Techniques</topic><topic>Inflammation</topic><topic>Injections</topic><topic>Microscopy, Electron, Scanning</topic><topic>Molecular weight</topic><topic>Otolaryngology</topic><topic>Patients</topic><topic>Pharmaceutical sciences</topic><topic>Polyvinyl Alcohol</topic><topic>Spectrophotometry</topic><topic>Studies</topic><topic>Sulfur</topic><topic>Surgery</topic><topic>Temperature</topic><topic>Tympanic Membrane</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ciftci, Zafer, MD</creatorcontrib><creatorcontrib>Deniz, Mahmut, MD</creatorcontrib><creatorcontrib>Yilmaz, Ibrahim, MSc</creatorcontrib><creatorcontrib>Ciftci, Halide Gunes, MD</creatorcontrib><creatorcontrib>Sirin, Duygu Yasar, PhD</creatorcontrib><creatorcontrib>Gultekin, Erdogan, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ciftci, Zafer, MD</au><au>Deniz, Mahmut, MD</au><au>Yilmaz, Ibrahim, MSc</au><au>Ciftci, Halide Gunes, MD</au><au>Sirin, Duygu Yasar, PhD</au><au>Gultekin, Erdogan, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>36</volume><issue>6</issue><spage>786</spage><epage>793</epage><pages>786-793</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Abstract The aim of this in-vitro experimental study was to design a novel drug delivery system that may permit controlled release of N-acetylcysteine (NAC) following intratympanic administration. The system was composed of two different solutions that attained a hydrogel form within seconds after getting into contact with each other. The authors performed swelling, pH and temperature tests and analysis of controlled release of NAC from this novel controlled release system. For the structure and porosity analysis of the hydrogel, an environmental scanning electron microscope (SEM) was used. The diameter of designed hydrogel showed an increase when pH was increased. In addition, in comparison to acidic values, the pore diameter of the hydrogel increased significantly especially in physiological level. The increase in the pore diameter was also directly proportional to the increase in temperature. Spectrophotometric analysis showed that the amount of NAC released into the medium was statistically significant ( p = 0.038, t = − 2.18, 95% CI; DF: 27). SEM analysis of the samples revealed a smooth surface topography and numerous porous structures. The authors are of the opinion that the designed hydrogel may be used as an alternative method for intratympanic delivery of NAC for otoprotective purposes. The disadvantages of intratympanic injection of the drug in its liquid form, including leakage through eustachian tube, restraining the patient in an uncomfortable position, necessity for repetitive injections and dose dependent inflammation of the middle ear epithelium, may also be avoided. Further in vivo studies should be conducted to assess its tolerability and effectivity.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26545472</pmid><doi>10.1016/j.amjoto.2015.08.004</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3307-085X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0196-0709 |
ispartof | American journal of otolaryngology, 2015-11, Vol.36 (6), p.786-793 |
issn | 0196-0709 1532-818X |
language | eng |
recordid | cdi_proquest_miscellaneous_1746892225 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Acetylcysteine - administration & dosage Biocompatible Materials Borates Chitosan Delayed-Action Preparations Design Drug Delivery Systems Drug dosages Free Radical Scavengers - administration & dosage Humans Hydrogel, Polyethylene Glycol Dimethacrylate Hydrogels Hydrogen-Ion Concentration In Vitro Techniques Inflammation Injections Microscopy, Electron, Scanning Molecular weight Otolaryngology Patients Pharmaceutical sciences Polyvinyl Alcohol Spectrophotometry Studies Sulfur Surgery Temperature Tympanic Membrane |
title | In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A02%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20analysis%20of%20a%20novel%20controlled%20release%20system%20designed%20for%20intratympanic%20administration%20of%20N-acetylcysteine:%20a%20preliminary%20report&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Ciftci,%20Zafer,%20MD&rft.date=2015-11-01&rft.volume=36&rft.issue=6&rft.spage=786&rft.epage=793&rft.pages=786-793&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2015.08.004&rft_dat=%3Cproquest_cross%3E3860565461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1731794110&rft_id=info:pmid/26545472&rft_els_id=S019607091500174X&rfr_iscdi=true |